Seres Therapeutics to Host Third Quarter 2015 Financial Results Conference Call and Webcast on Nov. 10, 2015

CAMBRIDGE, Mass.--()--Seres Therapeutics Inc. (NASDAQ:MCRB), a leading microbiome therapeutics platform company, announced today that management will host a conference call and live audio webcast on Tuesday, Nov. 10, 2015, at 10 a.m. EST to discuss financial results for the third quarter ended Sept. 30, 2015, and to provide a business update.

To access the conference call, please dial 888-834-1266 (domestic) or 440-996-5713 (international) and reference the conference ID number 65547781. To join the live webcast please visit the “Investors and Media” section of the Seres website at www.serestherapeutics.com.

A webcast replay will be available on the Seres website beginning approximately two hours after the event and will be archived for 14 days.

About Seres Therapeutics

Seres Therapeutics Inc. is a leading microbiome therapeutics platform company developing a novel class of biological drugs that are designed to treat disease by restoring the function of a dysbiotic microbiome.

Contacts

IR Contact:
Stern Investor Relations Inc.
Beth DelGiacco, 212-362-1200
Beth@sternir.com
or
PR Contact:
Ten Bridge Communications Inc.
Dan Quinn, 781-475-7974
Dan@tenbridgecommunications.com

Release Summary

Seres will be hosting a conference call and webcast on Nov. 10, 2015, to discuss financial results for the third quarter ended Sept. 30, 2015, and to provide a business update.

Contacts

IR Contact:
Stern Investor Relations Inc.
Beth DelGiacco, 212-362-1200
Beth@sternir.com
or
PR Contact:
Ten Bridge Communications Inc.
Dan Quinn, 781-475-7974
Dan@tenbridgecommunications.com